Generalized anxiety disorder in children and adolescents

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Children and adolescents with GAD suffer from excessive, pervasive worries that interfere with social, academic, and family functioning. The comorbidity rate with other anxiety disorders and major depression is high. The course tends to be chronic, and evidence shows continuity between anxiety disorders in youth and adulthood. Individual and group CBT and the incorporation of family anxiety management training have demonstrated efficacy in the treatment of childhood GAD. No double-blind, placebo-controlled, pharmacotherapy trials with adequate sample sizes for children and adolescents with GAD have been published. Preliminary data support the potential efficacy of selective serotonin reuptake inhibitors, buspirone, and high-potency benzodiazepines. Adequately powered, controlled, pharmacologic treatment trials are necessary. Future research should be directed toward comparing the relative efficacy of psychotherapy, pharmacotherapy, and both in the treatment of GAD in youth.

Original languageEnglish (US)
Pages (from-to)139-153
Number of pages15
JournalPsychiatric Clinics of North America
Volume24
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Anxiety Disorders
Buspirone
Drug Therapy
Serotonin Uptake Inhibitors
Benzodiazepines
Psychotherapy
Sample Size
Comorbidity
Anxiety
Placebos
Depression
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Generalized anxiety disorder in children and adolescents. / Wagner, Karen.

In: Psychiatric Clinics of North America, Vol. 24, No. 1, 2001, p. 139-153.

Research output: Contribution to journalArticle

@article{991b3be9a1844bca85a62a87e664ae66,
title = "Generalized anxiety disorder in children and adolescents",
abstract = "Children and adolescents with GAD suffer from excessive, pervasive worries that interfere with social, academic, and family functioning. The comorbidity rate with other anxiety disorders and major depression is high. The course tends to be chronic, and evidence shows continuity between anxiety disorders in youth and adulthood. Individual and group CBT and the incorporation of family anxiety management training have demonstrated efficacy in the treatment of childhood GAD. No double-blind, placebo-controlled, pharmacotherapy trials with adequate sample sizes for children and adolescents with GAD have been published. Preliminary data support the potential efficacy of selective serotonin reuptake inhibitors, buspirone, and high-potency benzodiazepines. Adequately powered, controlled, pharmacologic treatment trials are necessary. Future research should be directed toward comparing the relative efficacy of psychotherapy, pharmacotherapy, and both in the treatment of GAD in youth.",
author = "Karen Wagner",
year = "2001",
doi = "10.1016/S0193-953X(05)70210-0",
language = "English (US)",
volume = "24",
pages = "139--153",
journal = "Psychiatric Clinics of North America",
issn = "0193-953X",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Generalized anxiety disorder in children and adolescents

AU - Wagner, Karen

PY - 2001

Y1 - 2001

N2 - Children and adolescents with GAD suffer from excessive, pervasive worries that interfere with social, academic, and family functioning. The comorbidity rate with other anxiety disorders and major depression is high. The course tends to be chronic, and evidence shows continuity between anxiety disorders in youth and adulthood. Individual and group CBT and the incorporation of family anxiety management training have demonstrated efficacy in the treatment of childhood GAD. No double-blind, placebo-controlled, pharmacotherapy trials with adequate sample sizes for children and adolescents with GAD have been published. Preliminary data support the potential efficacy of selective serotonin reuptake inhibitors, buspirone, and high-potency benzodiazepines. Adequately powered, controlled, pharmacologic treatment trials are necessary. Future research should be directed toward comparing the relative efficacy of psychotherapy, pharmacotherapy, and both in the treatment of GAD in youth.

AB - Children and adolescents with GAD suffer from excessive, pervasive worries that interfere with social, academic, and family functioning. The comorbidity rate with other anxiety disorders and major depression is high. The course tends to be chronic, and evidence shows continuity between anxiety disorders in youth and adulthood. Individual and group CBT and the incorporation of family anxiety management training have demonstrated efficacy in the treatment of childhood GAD. No double-blind, placebo-controlled, pharmacotherapy trials with adequate sample sizes for children and adolescents with GAD have been published. Preliminary data support the potential efficacy of selective serotonin reuptake inhibitors, buspirone, and high-potency benzodiazepines. Adequately powered, controlled, pharmacologic treatment trials are necessary. Future research should be directed toward comparing the relative efficacy of psychotherapy, pharmacotherapy, and both in the treatment of GAD in youth.

UR - http://www.scopus.com/inward/record.url?scp=0035130390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035130390&partnerID=8YFLogxK

U2 - 10.1016/S0193-953X(05)70210-0

DO - 10.1016/S0193-953X(05)70210-0

M3 - Article

VL - 24

SP - 139

EP - 153

JO - Psychiatric Clinics of North America

JF - Psychiatric Clinics of North America

SN - 0193-953X

IS - 1

ER -